Research

Our Approach: From Discovery to Therapeutic Targets in PAH

Our research bridges discovery and translational science to uncover the molecular mechanisms of PAH and related pulmonary vascular diseases. We integrate multiomics, systems biology, and both in vitro and in vivo models to identify dysregulated pathways that drive vascular remodeling and disease progression, with the goal of advancing targeted therapies for patients.

Diagram of omics-based disease target discovery, validation, and therapeutic mechanism affecting cells and blood vessels.